Impact of Using a Low Anti-Xa Target Heparin Protocol on Hemocompatibility-Related Outcomes after Implantation of a HeartMate 3 Device

Volume: 40, Issue: 4, Pages: S87 - S88
Published: Apr 1, 2021
Abstract
Purpose null To evaluate early hemocompatibility-related outcomes after implementation of a low anti-Xa target heparin protocol following implantation of the HeartMate 3 Left Ventricular Assist Device (LVAD). null null null Methods null We reviewed hemocompatibility-related outcomes including mediastinal bleeding, gastrointestinal bleeding (GIB), stroke, and pump thrombosis (PT) events in recipients of HeartMate 3 LVADs before and after...
Paper Details
Title
Impact of Using a Low Anti-Xa Target Heparin Protocol on Hemocompatibility-Related Outcomes after Implantation of a HeartMate 3 Device
Published Date
Apr 1, 2021
Volume
40
Issue
4
Pages
S87 - S88
Citation AnalysisPro
  • Scinapse’s Top 10 Citation Journals & Affiliations graph reveals the quality and authenticity of citations received by a paper.
  • Discover whether citations have been inflated due to self-citations, or if citations include institutional bias.